Management of Hemodialysis Patients with Heart Failure and Hypotension
Immediate Acute Management
- The American College of Cardiology recommends stopping or reducing ultrafiltration immediately to prevent further blood pressure decline and allow vascular refilling in hemodialysis patients with heart failure and hypotension 1, 2
- Placing the patient in Trendelenburg position (head down, legs elevated) can improve venous return and increase blood pressure in hemodialysis patients with heart failure and hypotension 1, 2
- Administering supplemental oxygen can improve tissue oxygenation and reduce symptoms related to hypoxemia in hemodialysis patients with heart failure and hypotension 1, 2, 3
- Giving an intravenous normal saline bolus (typically 100-250 mL) can rapidly expand plasma volume if the patient shows evidence of hypoperfusion, though avoid routine saline administration for every episode as this perpetuates volume overload 1, 2
Assessment of Volume Status and Cardiac Function
- Assessing for elevated cardiac filling pressures (elevated jugular venous pressure, pulmonary congestion on exam) can determine if hypotension is occurring despite volume overload in hemodialysis patients with heart failure 3
- In patients with clinical evidence of hypotension associated with hypoperfusion AND obvious evidence of elevated cardiac filling pressures, consider intravenous inotropic or vasopressor drugs to maintain systemic perfusion while more definitive therapy is considered 3
- Invasive hemodynamic monitoring should be performed to guide therapy in patients in respiratory distress or with clinical evidence of impaired perfusion when adequacy or excess of intracardiac filling pressures cannot be determined from clinical assessment 3
Dialysis Prescription Modifications to Prevent Recurrence
- Keeping ultrafiltration rates below 6 mL/h/kg can reduce the risk of hypotension and mortality in hemodialysis patients with heart failure 1
- Extending treatment time to a minimum of 4 hours per session can slow the ultrafiltration rate and allow adequate vascular refilling in hemodialysis patients with heart failure 1, 2
- Increasing dialysis frequency from twice to three times weekly can reduce the risk of hypotension in patients with excessive interdialytic weight gain requiring aggressive ultrafiltration 1
Dialysate Modifications
- Increasing dialysate sodium concentration to 148 mEq/L can maintain vascular stability in hemodialysis patients with heart failure 1, 2, 4
- Reducing dialysate temperature from 37°C to 34-35°C can increase peripheral vasoconstriction and cardiac output, reducing symptomatic hypotension in hemodialysis patients with heart failure 1, 2, 4, 5
Heart Failure Medication Management During Dialysis
- Continuing ACE inhibitors or ARBs and beta-blockers during hospitalization can improve outcomes in hemodialysis patients with heart failure and reduced ejection fraction 3, 6
- Withholding or reducing beta-blocker therapy may be necessary in patients hospitalized after recent initiation or increase in beta-blocker therapy, or with marked volume overload or marginal/low cardiac output 6
Pharmacological Management of Intradialytic Hypotension
- Administering midodrine (oral α1-adrenergic agonist) 30 minutes before dialysis initiation can increase peripheral vascular resistance and enhance venous return in hemodialysis patients with heart failure 1, 4
Diuretic Management in Heart Failure Patients
- Administering intravenous loop diuretics promptly can reduce morbidity in patients with fluid overload and heart failure 3, 6, 8
- Monitoring urine output and signs of congestion serially, adjusting diuretic dose to relieve symptoms and reduce extracellular fluid volume excess, is crucial in patients with heart failure 3, 6
Long-Term Prevention Strategies
- Limiting sodium intake to <5.8 g/day can reduce thirst and interdialytic weight gain in hemodialysis patients with heart failure 1, 2
- Restricting interdialytic weight gain to <3% of body weight between sessions can prevent excessive ultrafiltration requirements in hemodialysis patients with heart failure 1, 2
- Maintaining hemoglobin at 11 g/dL can improve oxygen-carrying capacity and cardiovascular compensation during ultrafiltration in hemodialysis patients with heart failure 1, 4, 5
Monitoring and Follow-up
- Monitoring fluid intake and output carefully, along with vital signs and body weight determined at the same time each day, is essential in hemodialysis patients with heart failure 3, 6
- Measuring daily serum electrolytes, urea nitrogen, and creatinine concentrations can guide therapy in patients with heart failure and hemodialysis 3, 6, 8